Skip to search.
 FTSE 100 Down 0.58%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
13.57 Up 0.50(3.83%) 27 Mar 20:00
|After Hours: : 13.57 0.00 (0.00%) 27 Mar 20:33
Add to Portfolio
Prev Close:13.07
Open:13.08
Bid:12.90 x 300
Ask:13.58 x 500
1y Target Est:25.31
Beta:1.75
Next Earnings Date: 7-May-15SRPT Earnings announcement
Day's Range:13.08 - 13.68
52wk Range:11.33 - 40.00
Volume:764,449
Avg Vol (3m):830,540
Market Cap:560.59m
P/E (ttm):N/A
EPS (ttm):-3.39
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SRPTUp 3.83%560.59m
ALNYUp 4.44%8.72b
GSKUp 0.77%113.11b
ISISUp 3.63%7.54b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):55.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-4.21
Quarterly EPS Est (Mar-15) :-1.00
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):15.50

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback